Paediatric patients seen in 18 emergency departments during the COVID-19 pandemic

Ran D Goldman1,2, Eric Grafstein3,4, Neil Barclay4,5

  • 1The Pediatric Research in Emergency Therapeutics (PRETx) Program, Division of Emergency Medicine, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada rgoldman@cw.bc.ca.

Insights

Pediatric emergency department visits in British Columbia dropped significantly during COVID-19 lockdowns, primarily due to fewer cases of minor illnesses. This shift impacted overall patient numbers and acuity levels in emergency care settings.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health
  • Epidemiology

Background:

  • COVID-19 pandemic prompted public health measures like stay-at-home orders and service closures in British Columbia.
  • Hospitals maintained emergency department (ED) operations for urgent care during the pandemic.
  • Primary physician offices largely closed, shifting care needs to EDs.

Purpose of the Study:

  • To analyze changes in pediatric emergency department presentations during the COVID-19 pandemic.
  • To compare patient acuity and visit numbers pre-pandemic, during the pandemic, and against the prior year.
  • To understand the impact of public health measures on pediatric emergency care utilization.

Main Methods:

  • Analysis of records from 18 EDs in British Columbia, Canada.
  • Inclusion of pediatric patients aged 0-16 years.
  • Comparison of prepandemic, early pandemic, peak pandemic, and prior year data, excluding specific patient groups.

Main Results:

  • Overall ED visits for children decreased by 57% (children's hospital) and 70% (general hospitals).
  • Average daily visits dropped significantly during the peak pandemic compared to prepandemic levels.
  • Admission rates increased due to a decrease in lower-acuity visits; fever and gastrointestinal complaints saw the largest reduction in visits.

Conclusions:

  • Pediatric emergency medicine attendances decreased to one-third of normal during the 2020 COVID-19 lockdown in British Columbia.
  • The reduction was predominantly observed in minor illnesses not typically requiring hospital admission.
  • The findings highlight a significant shift in the pattern of pediatric emergency care utilization during the pandemic.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
125
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
131
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
100
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K